ID | Name | Number of studies | |
---|---|---|---|
CL_0000786 | plasma cell | 61 | |
CL_0000985 | IgG plasma cell | 10 | |
CL_0000987 | IgA plasma cell | 9 | |
CL_0000986 | IgM plasma cell | 4 | |
CL_0000974 | long lived plasma cell | 0 | |
CL_0000947 | IgE plasma cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
TNFRSF17 | 22 | 51% ± 19% | 0 | 5 | |
FCRL5 | 18 | 41% ± 14% | 0 | 7 | |
MEI1 | 13 | 38% ± 14% | 0 | 3 | |
IGLL5 | 13 | 61% ± 26% | 0 | 7 | |
SPAG4 | 12 | 30% ± 12% | 0 | 2 | |
TNFRSF13B | 12 | 34% ± 13% | 0 | 4 | |
MANEA | 9 | 27% ± 6% | 0 | 0 | |
JSRP1 | 9 | 25% ± 7% | 0 | 1 | |
CD79A | 24 | 63% ± 20% | 1 | 13 | |
POU2AF1 | 22 | 52% ± 18% | 1 | 12 | |
CD27 | 21 | 58% ± 20% | 1 | 30 | |
ZBP1 | 14 | 39% ± 21% | 1 | 11 | |
FAM30A | 11 | 23% ± 5% | 1 | 6 | |
DERL3 | 27 | 70% ± 21% | 2 | 7 | |
SLAMF7 | 19 | 37% ± 12% | 2 | 18 | |
IRF4 | 18 | 27% ± 10% | 2 | 9 | |
TXNDC5 | 14 | 49% ± 25% | 2 | 4 | |
TP53INP1 | 14 | 34% ± 13% | 2 | 11 | |
CD79B | 13 | 40% ± 15% | 2 | 13 | |
MZB1 | 32 | 81% ± 21% | 3 | 15 | |
NCF1 | 16 | 44% ± 19% | 3 | 36 | |
SDC1 | 14 | 34% ± 12% | 3 | 20 | |
SYVN1 | 13 | 30% ± 13% | 3 | 11 | |
RAB30 | 13 | 31% ± 13% | 3 | 16 | |
RGS1 | 16 | 40% ± 13% | 3 | 46 | |
HSH2D | 13 | 36% ± 13% | 3 | 21 | |
TOR3A | 12 | 30% ± 14% | 3 | 13 | |
PIM2 | 26 | 49% ± 19% | 4 | 36 | |
TENT5C | 21 | 55% ± 15% | 4 | 28 | |
CYTIP | 23 | 42% ± 16% | 4 | 57 |
GO_0030970 | Biological process | retrograde protein transport, ER to cytosol |
GO_0034620 | Biological process | cellular response to unfolded protein |
GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
GO_0022417 | Biological process | protein maturation by protein folding |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0097278 | Biological process | complement-dependent cytotoxicity |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_0060545 | Biological process | positive regulation of necroptotic process |
GO_0002260 | Biological process | lymphocyte homeostasis |
GO_0006613 | Biological process | cotranslational protein targeting to membrane |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_0051223 | Biological process | regulation of protein transport |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0071569 | Biological process | protein ufmylation |
GO_0001711 | Biological process | endodermal cell fate commitment |
GO_0002314 | Biological process | germinal center B cell differentiation |
GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
GO_0036498 | Biological process | IRE1-mediated unfolded protein response |
GO_0043405 | Biological process | regulation of MAP kinase activity |
GO_0002502 | Biological process | peptide antigen assembly with MHC class I protein complex |
GO_0001788 | Biological process | antibody-dependent cellular cytotoxicity |
GO_0044571 | Biological process | [2Fe-2S] cluster assembly |
GO_0160063 | Biological process | multi-pass transmembrane protein insertion into ER membrane |
GO_0032368 | Biological process | regulation of lipid transport |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0060267 | Biological process | positive regulation of respiratory burst |
GO_0046626 | Biological process | regulation of insulin receptor signaling pathway |
GO_0006617 | Biological process | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition |
GO_0006614 | Biological process | SRP-dependent cotranslational protein targeting to membrane |
Cell type name | plasma cell |
Synonyms | plasma B cell plasma B-cell plasmacyte plasmocyte |
Description | A terminally differentiated, post-mitotic, antibody secreting cell of the B cell lineage with the phenotype CD138-positive, surface immunonoglobulin-negative, and MHC Class II-negative. Plasma cells are oval or round with extensive rough endoplasmic reticulum, a well-developed Golgi apparatus, and a round nucleus having a characteristic cartwheel heterochromatin pattern and are devoted to producing large amounts of immunoglobulin. |
Parent | CL_0000946 |